Current
2.5×
5-Year Average
2.2×
All-Time High
4.9×
All-Time Low
1.5×
P/B Ratio daily chart for Labcorp Holdings (LH)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/B Ratio for Labcorp Holdings (LH) from 2001 to 2025
| 2025 | $20.70B | $8.62B | 2.4× | +0.0× | |
| 2024 | $19.17B | $8.05B | 2.4× | -0.1× | |
| 2023 | $19.30B | $7.88B | 2.5× | +0.7× | |
| 2022 | $17.90B | $10.10B | 1.8× | -0.7× | |
| 2021 | $25.72B | $10.27B | 2.5× | +0.7× | |
| 2020 | $17.05B | $9.44B | 1.8× | -0.1× | |
| 2019 | $14.13B | $7.57B | 1.9× | +0.3× | |
| 2018 | $10.88B | $6.97B | 1.6× | -0.5× | |
| 2017 | $14.00B | $6.80B | 2.1× | -0.0× | |
| 2016 | $11.39B | $5.51B | 2.1× | -0.1× | |
| 2015 | $10.76B | $4.95B | 2.2× | -0.6× | |
| 2014 | $7.84B | $2.82B | 2.8× | +0.1× | |
| 2013 | $6.73B | $2.49B | 2.7× | +0.1× | |
| 2012 | $6.96B | $2.72B | 2.6× | -0.3× | |
| 2011 | $7.17B | $2.50B | 2.9× | -0.2× | |
| 2010 | $7.57B | $2.47B | 3.1× | -0.2× | |
| 2009 | $6.79B | $2.11B | 3.2× | -0.3× | |
| 2008 | $5.95B | $1.69B | 3.5× | -0.7× | |
| 2007 | $7.35B | $1.73B | 4.3× | +0.4× | |
| 2006 | $7.70B | $1.98B | 3.9× | +0.7× | |
| 2005 | $6.06B | $1.89B | 3.2× | +0.3× | |
| 2004 | $5.92B | $2.00B | 3.0× | +0.6× | |
| 2003 | $4.47B | $1.90B | 2.4× | +0.6× | |
| 2002 | $2.89B | $1.61B | 1.8× | -2.7× | |
| 2001 | $4.86B | $1.09B | 4.5× | — |
- 20252.4×
- 20242.4×
- 20232.5×
- 20221.8×
- 20212.5×
- 20201.8×
- 20191.9×
- 20181.6×
- 20172.1×
- 20162.1×
- 20152.2×
- 20142.8×
- 20132.7×
- 20122.6×
- 20112.9×
- 20103.1×
- 20093.2×
- 20083.5×
- 20074.3×
- 20063.9×
- 20053.2×
- 20043.0×
- 20032.4×
- 20021.8×
- 20014.5×
About P/B Ratio at Labcorp Holdings (LH)
Labcorp Holdings (LH) P/B ratio is 2.5× as of June 5, 2026. The 5-year average is 2.2×. The sector median currently stands at 3.4×. The current ratio is at the 81th percentile of its own 10-year history.
Labcorp Holdings (LH) historical P/B ratio has ranged from a low of 1.5× (2020) to a high of 4.9× (2002) in the available daily series.
The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.
Labcorp Holdings P/B Ratio by Year
Labcorp Holdings P/B Ratio 2025: 2.4×
Labcorp Holdings (LH) P/B ratio in 2025 was 2.4×, expanded from 2.4× the prior year.
Labcorp Holdings P/B Ratio 2024: 2.4×
Labcorp Holdings (LH) P/B ratio in 2024 was 2.4×, contracted from 2.5× the prior year.
Labcorp Holdings P/B Ratio 2023: 2.5×
Labcorp Holdings (LH) P/B ratio in 2023 was 2.5×, expanded from 1.8× the prior year.
Labcorp Holdings P/B Ratio 2022: 1.8×
Labcorp Holdings (LH) P/B ratio in 2022 was 1.8×, contracted from 2.5× the prior year.
Labcorp Holdings P/B Ratio 2021: 2.5×
Labcorp Holdings (LH) P/B ratio in 2021 was 2.5×.
Sector peers by P/B Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/B Ratio — table
Healthcare peers of Labcorp Holdings (LH), ranked by P/B ratio.
| 3.0× | |
| 2.9× | |
| 2.7× | |
| 2.6× | |
| 2.6× | |
| 2.5× | |
| 2.4× | |
| 2.4× | |
| 2.3× | |
| 1.8× | |
| 1.8× | |
| 1.7× | |
| 1.7× | |
| 1.6× | |
| 1.5× | |
| 1.5× | |
| 1.5× | |
| 1.4× | |
| 1.4× | |
| 1.4× | |
| 1.2× | |
| 1.2× | |
| 1.1× | |
| 1.1× | |
| 0.8× |
- 2.7×
- 2.4×
- 2.3×
- 1.8×
- 1.7×
- 1.4×
- 1.4×
- 1.2×
- 1.1×
- 1.1×
- 0.8×
Frequently asked questions
Labcorp Holdings (LH) Key Financials
Charts, filings, and peer comparison for every metric